T. Rowe Price Associates’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Buy |
22,685
+5,276
| +30% | +$35.1K | ﹤0.01% | 2800 |
|
|
2025
Q1 | $160K | Buy |
17,409
+2,215
| +15% | +$20.4K | ﹤0.01% | 2712 |
|
|
2024
Q4 | $160K | Buy |
15,194
+3,153
| +26% | +$33.2K | ﹤0.01% | 2745 |
|
|
2024
Q3 | $144K | Hold |
12,041
| – | – | ﹤0.01% | 2754 |
|
|
2024
Q2 | $0 | Buy |
+12,041
| New | – | ﹤0.01% | 2941 |
|
|
2023
Q4 | – | Sell |
-62,679
| Closed | -$207K | – | 2907 |
|
|
2023
Q3 | $207K | Buy |
+62,679
| New | +$207K | ﹤0.01% | 2486 |
|
|
2021
Q4 | – | Sell |
-2,674,299
| Closed | -$37.9M | – | 2984 |
|
|
2021
Q3 | $37.9M | Buy |
+2,674,299
| New | +$37.9M | ﹤0.01% | 1110 |
|